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Abstract
Background: The effects of hypercholesterolemia on vasomotricity in apolipoprotein E-deficient (ApoE) mice, a 
murine model of spontaneous atherosclerosis, are still unclear. The studies were mostly performed in conductance 
vessels from male mice fed a high-fat diet. In the present study, we evaluated the endothelial function of resistance 
vessels from normal C57BL/6 (C57) and hypercholesterolemic (ApoE) female mice in both normal and ovariectomized 
conditions.
Methods: Twenty week-old C57 and ApoE mice underwent ovariectomy or sham surgery and were studied 30 days 
later. The vascular reactivities to norepinephrine (NE, 10-9 to 2 × 10-3 mol/L), acetylcholine (ACh) and sodium 
nitroprusside (SNP) (10-10 to 10-3 mol/L) were evaluated in the isolated mesenteric arteriolar bed through dose-
response curves.
Results: ACh-induced relaxation was significantly reduced (P < 0.05) in ApoE compared with C57 animals, as indicated 
by both the maximal response (37 ± 4% vs. 72 ± 1%) and the LogEC50 (-5.67 ± 0.18 vs. -6.23 ± 0.09 mol/L). Ovariectomy 
caused a significant impairment in ACh-induced relaxation in the C57 group (maximal response: 61 ± 4%) but did not 
worsen the deficient state of relaxation in ApoE animals (maximal response: 39 ± 5%). SNP-induced vasorelaxation and 
NE-induced vasoconstriction were similar in ApoE and C57 female mice.
Conclusion: These data show an impairment of endothelial function in the resistance vessels of spontaneously 
atherosclerotic (ApoE-deficient) female mice compared with normal (C57) female mice. The endothelial dysfunction in 
hypercholesterolemic animals was so marked that ovariectomy, which impaired endothelial function in C57 mice, did 
not cause additional vascular damage in ApoE-deficient mice.
Background
Atherosclerosis is a slow, progressive and multifactorial
disease that results from interactions between genetic
and environmental factors [1]. The murine model that
lacks the gene encoding apolipoprotein E (ApoE) and
spontaneously develops hypercholesterolemia and ath-
erosclerotic lesions similar to those found in human
beings [2,3] has greatly contributed to the understanding
of this disease. In this animal, on a chow diet, as early as
10 weeks of age, monocyte adhesions are observed, fol-
lowed by intermediate lesions containing foam and
smooth muscle cells at 15 weeks and sequentially by
fibrous plaques at 20 weeks of age [4]. Although endothe-
lial dysfunction has been considered one of the early
steps in atherosclerosis [5], its occurrence in ApoE-defi-
cient mice is still controversial. Studies in conductance
vessels of male and female ApoE-deficient mice have
shown both normal endothelial function [6,7] and
endothelial dysfunction [8-11]. On the other hand, stud-
ies in resistance vessels from ApoE-deficient mice have
shown normal endothelial function in males [12,13] and
endothelial dysfunction in females [14]. It is well estab-
lished that estrogens exert several direct effects on the
vessel wall [15-18] and that post-menopausal women [19]
are known to present an elevated risk of cardiovascular
events, which can be reduced by exogenous administra-
tion of 17β-estradiol [20,21]. In accordance with this
view, it has been shown that the loss of female hormones
leads to the impairment of endothelial function in rats
[22-24], but this was not yet investigated in mice.
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The importance of studying resistance vessels is based
on the fact that arterioles act as control conduits through
which blood is released into tissue microcirculation.
Considering that the responsiveness of resistance vessels
is still poorly understood in the mouse and that there are
few studies in atherosclerotic female mice, the present
study was designed to evaluate endothelial function in
the isolated mesenteric arteriolar bed of C57BL/6 and
ApoE-deficient mice under both normal and ovariectomy
conditions.
Methods
The experiments were performed using 20-24-week-old
female C57BL/6 (C57) and ApoE mice obtained from the
animal facilities of the Health Sciences Center at the Fed-
eral University of Espirito Santo. The animals were
housed according to institutional guidelines for animal
research and fed a normal diet. The procedures were pre-
viously approved by the institutional Ethics Committee
for Use of Animals (CEUA-EMESCAM, protocol #002/
2009) and were conducted in accordance with the inter-
national guidelines for care and use of laboratory animals.
At 20 weeks of age, C57 and ApoE mice underwent ova-
riectomy, as previously described [22]. Thirty days after
ovariectomy, the animals were anesthetized (ketamine/
xylazine, 91.0/9.1 mg/kg, i.p.) and blood samples were
collected for determination of 17β-estradiol and total
cholesterol levels. 17β-estradiol levels were determined
using chemiluminescence assays (Marcos Daniel Labora-
tory, Vitoria, Brazil) and total cholesterol levels were
measured colorimetrically using a commercial kit (Bio-
clin, Sao Paulo, Brazil). After blood sample collection, the
superior mesenteric artery was cannulated. The mesen-
teric arteriolar bed was then transferred to a 37°C water
c o n t a i n e r  a n d  p e r f u s e d  a t  a  c o n s t a n t  r a t e  ( 2  m L / m i n )
with oxygenated (95% O2 - 5% CO2 mixture) physiological
salt solution (in mmol/L: 130 NaCl, 4.7 KCl, 1.6
CaCl2·2H2O, 1.18 KH2PO4, 4.7 MgSO4·7H2O, 14.9
NaHCO3, 0.026 EDTA and 11.1 glucose) using a peristal-
tic pump (Harvard Apparatus, Holliston, MA, USA). Per-
fusion pressure was monitored via a T-tube inserted
between the pump and the inflow cannula and connected
to a pressure transducer and a data acquisition system
(BioPac Systems, Goleta, CA, USA). The dose-response
curves to norepinephrine (NE, Sigma Chemical Co. Saint
Luis, MO, USA, 10-9 to 2 × 10-3 mol/L), acetylcholine
(ACh, Sigma, 10-10 to 10-3 mol/L) and sodium nitroprus-
side (SNP, Sigma, 10-10 to 10-3 m o l / L )  w e r e  t h e n  p e r -
formed in the isolated mesenteric arteriolar bed. The
vascular responses were evaluated as changes in the per-
fusion pressure and the vasodilator responses to ACh and
SNP were calculated as percentages of the contractions
induced by NE (5 × 10-6 mol/L).
All data are expressed as means ± SEM. Statistical anal-
ysis was performed with 1- or 2-way ANOVA followed by
Tukey's post hoc test for multiple comparisons. The level
of significance was set at P < 0.05.
Results
Body weight, uterus weight, uterus weight/body weight
ratio, plasma 17β-estradiol and cholesterol levels are
summarized in Table 1. Thirty days after ovariectomy,
body weight was not altered; however, uterus weight was
significantly reduced in ovariectomized groups, with no
differences between C57 and ApoE animals. Conse-
quently, the uterus weight/body weight ratio was dimin-
ished in about 80% in the ovariectomized groups when
compared with the respective sham groups. The success
of ovariectomy was also confirmed by plasma 17β-estra-
diol levels, which were significantly lower in ovariecto-
mized groups (2-fold, P < 0.01) in comparison with sham
animals, also without differences between C57 and ApoE
mice. As expected, plasma cholesterol levels were signifi-
Table 1: Body and uterus weight and plasma 17β-estradiol and cholesterol levels in C57 and ApoE-deficient mice groups
Parameters C57 ApoE
Sham OVX Sham OVX
Body weight (g) 25.9 ± 0.5 (22) 26.8 ± 0.6 (22) 26.3 ± 0.6 (12) 25.5 ± 0.7 (12)
Uterus weight (mg) 30.3 ± 1.8 (22) 5.4 ± 0.7* (22) 36.2 ± 1.6 (12) 5.9 ± 1.3† (12)
Uterus weight/body 
weight (mg/g)
1.18 ± 0.10 (22) 0.20 ± 0.02* (22) 1.38 ± 0.07 (12) 0.23 ± 0.05† (12)
Plasma 17β-estradiol 
(pmol/L)
128 ± 8 (14) 61 ± 4* (13) 152 ± 12 (11) 71 ± 3† (9)
Plasma cholesterol 
(mmol/L)
1.66 ± 0.13 (16) 1.42 ± 0.11 (13) 10.77 ± 1.02* (11) 9.64 ± 0.88* (9)
Data are reported as means ± SEM of the number of animals indicated in parentheses.
OVX: ovariectomized. *P < 0.05 vs C57 Sham; †P < 0.05 vs ApoE Sham (ANOVA).Cola et al. Lipids in Health and Disease 2010, 9:51
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cantly higher (6.5-fold) in ApoE than in C57 mice. Hyper-
cholesterolemia levels of ApoE mice were not affected by
ovariectomy.
The endothelium-dependent vasodilatation of the iso-
lated mesenteric arteriolar bed in response to ACh is
shown in Figure 1. The vascular responsiveness to ACh
was significantly reduced in ApoE animals compared
with C57 animals, as indicated by both the maximal
response (37 ± 4% vs. 72 ± 1%, P < 0.01) and the LogEC50
(-5.67 ± 0.18 vs. -6.23 ± 0.09 mol/L, P < 0.05) (panel A).
Ovariectomy caused a significant impairment in the
ACh-induced relaxation in the C57 group (panel C) but
did not worsen the deficient state of relaxation in ApoE
animals (panel D). Even after ovariectomy, ACh-induced
relaxation still was significantly diminished in ApoE ani-
mals compared with C57 animals (maximal response: 39
± 5% vs. 61 ± 4%, P < 0.01, panel B).
The endothelium-independent vascular smooth muscle
r e l a x a t i o n  i n  A p o E  m i c e  p r o d u c e d  b y  t h e  n i t r i c  o x i d e
donor SNP was statistically similar the relaxation in C57
mice in both intact and ovariectomized animals. The vas-
cular constriction response to NE was also not affected
by the hypercholesterolemic condition of ApoE animals
or by ovariectomy.
Discussion
One of the hallmarks of atherosclerosis in humans is the
impairment of endothelial function [5]. The ApoE-defi-
cient mouse is considered one of the most relevant mod-
els for atherosclerosis because this animal develops
Figure 1 Endothelium-dependent relaxations produced by acetylcholine in mesenteric arteries of C57 and ApoE mice 30 days after ova-
riectomy (OVX) or sham surgery (Sham). Responses are expressed as the percentage of relaxations relative to the NE-induced precontractions. A: 
comparison between C57 Sham and ApoE Sham. B: comparison between C57 OVX and ApoE OVX. C and D: effects of ovariectomy on acetylcholine-
induced vasorelaxation in C57 and ApoE mice, respectively. Data are reported as means ± SEM (n = 8 to 10 per group). *P < 0.05, **P < 0.01 vs respective 
control (ANOVA).Cola et al. Lipids in Health and Disease 2010, 9:51
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spontaneous arterial lesions [2,3]. Resistance vessels of
male ApoE mice generally present normal endothelial
function on a normal chow diet [12,13] and endothelial
dysfunction is only observed in high-fat diet conditions
[25]. In contrast, female ApoE mice, even on a normal
diet, show endothelial dysfunction in aorta and cerebral
resistance vessels [9,14]. In the present study, we show
that the isolated mesenteric arteriolar bed of female
ApoE-deficient mice fed a normal diet also presents
endothelial dysfunction, as indicated by the marked
decrease in ACh-induced vasorelaxation. The impair-
m e n t of  vasor e laxa ti on does not  a ppea r  t o in vo lve  t he
vascular smooth muscle because the endothelium-inde-
pendent vasorelaxation to SNP was preserved in the
female ApoE-deficient mouse. On the other hand, in the
present study we observed a normal NE-induced vaso-
constriction in resistance vessels of female ApoE-defi-
cient mice, corroborating the finding by others showing
preserved responses to NE in aorta rings of female ApoE-
deficient mice under both normal and high-fat diets [8].
In this model, the normal vascular responsiveness to NE
seems to be related only to females because in previous
study it was found an exacerbated NE-induced vasocon-
striction in male mice [12].
Gender is a potent risk factor for cardiovascular dis-
e a s e s  [ 2 6 ] .  I n  c o n t r a s t  w i t h  f e m a l e s ,  m a l e s  h a v e  a n
increased prevalence of atherosclerotic-based diseases,
such ischemic heart disease, stroke and aortic aneurysms
[27,28]. In the present study, we investigated resistance
vessel responsiveness in both normal and spontaneously
atherosclerotic female mice. In agreement with others
[29-31], mice subjected to the removal of ovaries pre-
sented a smaller uterus weight in comparison with non-
castrated mice. In the present study, we observed that
ovariectomy led to a significant reduction in ACh-
induced vasorelaxation in female C57 mice. Although
impairment of endothelial function has been observed in
conductance vessels of castrated female mice, dysfunc-
tion of resistance vessels of C57 animals had not yet been
reported. Based on other studies, this finding could be
explained by the fact that estrogen has direct beneficial
effects on endothelial function by augmenting prostacy-
clin and NO synthesis [17,32-34].
Contrasting with males [12,13], we observed that
female ApoE-deficient mice on a normal chow diet show
endothelial dysfunction of resistance vessels. Similar
results have been observed by others in the aorta and
cerebral arterioles of female ApoE-deficient mice [9,14].
These observations corroborate the finding that female
ApoE-deficient mice present a higher vascular lesion area
than male mice [35], which appears to be related to direct
effects of estrogen on the specific immune activation on
female mice. In the present study, the ovariectomy of
female ApoE-deficient mice did not cause additional
damage to the endothelial function of resistance vessels,
probably because the animals already presented marked
endothelial dysfunction. This finding seems to be related
only to the ApoE-deficient mouse because it is well
known that in other models of cardiovascular diseases
estrogen deficiency leads to endothelial dysfunction
[17,22]. Similar to C57 female mice, we did not observe
any effect of ovariectomy on the NE-induced vasocon-
striction in resistance vessels of female ApoE-deficient
mice, corroborating the finding that female 17β-estrogen
receptor knockout mice did not present any change in
NE-induced vasoconstriction [36].
In conclusion, the current findings demonstrated an
impairment of endothelial function in resistance vessels
of spontaneously atherosclerotic (ApoE-deficient) female
mice compared with normal (C57) female mice. The
endothelial dysfunction was so marked that ovariectomy,
which impaired the endothelial function in C57, did not
cause additional damage in ApoE-deficient mice. Further
studies will be required to elucidate the mechanisms
involved in the endothelial dysfunction in these animals.
We speculate that increased superoxide anion production
and reduced activity of endothelial nitric oxide synthase
could contribute to the endothelial dysfunction in female
ApoE-deficient mice.
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